Ophthalmology

Top Story

PUBLICATION EXCLUSIVE: ASCRS Research Council aims to mirror success of DRCR.net

March 22, 2017

The Diabetic Retinopathy Clinical Research Network is a collaboration among the National Eye Institute, the National Institute of Diabetes and Digestive and Kidney Diseases, industry and more than 400 committed retina specialists at 120 practices. The purpose of DRCR.net is to facilitate multicenter clinical research into diabetes-associated eye disease, including diabetic retinopathy, diabetic macular edema, cataract, glaucoma, vitreous hemorrhage and other eye conditions. The network is funded primarily by federal grants from the NEI along with industry. As discussed in the accompanying cover story, DRCR.net clinical trials have contributed greatly to our understanding and treatment of diabetic eye disease.

The DRCR.net was established in September 2002 and is a fantastic example of public-private collaboration. This constructive collaboration has generated nearly 30 clinical trial protocols and more than 70 peer-reviewed publications and dramatically impacted the treatment of patients worldwide. Participation is open to any retina specialist who meets the training and practice profile requirements. In addition, any retina specialist can submit a study protocol idea. The network chair is Lee Jampol, MD, of Northwestern University Feinberg School of Medicine. The coordinating center is the Jaeb Center for Health Research in Tampa, Florida, directed by Adam R. Glassman, MS, and Roy W. Beck, MD, PhD. The NEI DRCR.net Project Officer is Eleanor Schron, PhD, RN.

AMA urges members of Congress to oppose American Health Care Act

March 22, 2017
The American Medical Association today released a letter to members of Congress urging them to oppose the American Health Care Act, citing projections that it will cost…

ACP: New amendments to AHCA ‘even less acceptable’

March 22, 2017
ACP recently sent a letter to the Congressional leadership in strong opposition of the manager’s amendments to the American Health Care Act, arguing that several…

Trump’s FDA pick brings ‘relief,’ but ties to industry criticized

March 22, 2017
When President Donald J. Trump nominated Scott Gottlieb, MD, to be the next FDA commissioner, the announcement was met with relief by some that the agency’s…
In the Journals

Combined procedures do not increase risk of pseudophakic CME

March 22, 2017
The combination of ab interno glaucoma surgery with phacoemulsification does not increase the risk of pseudophakic cystoid macular edema as compared with…
More News Headlines »
Original ArticleOpen Access

A New Matrix Therapy Agent for Faster Corneal Healing and Less Ocular Discomfort Following Epi-off Accelerated Corneal Cross-linking in Progressive Keratoconus

Journal of Refractive Surgery, March 2017, Volume 33 Issue 3
To investigate the hypothesis that a new matrix therapy agent (ReGeneraTing Agent, [RGTA]) would speed up the corneal…
More »
CME

Perspectives From Around the World in the Management of Chronic Posterior Noninfectious Uveitis

This CME program brings you valuable perspectives from international uveitis experts. Watch and listen to them cover…
More »
Featured
World Retina Congress

World Retina Congress

Video
Meeting News

VIDEO: HR experts tackle hot topics from immigration to Generation Z

March 1, 2017
More »
Advertisement
Advertisement